Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants.
Hendeles
Leslie
L
College of Pharmacy and the Pediatric Pulmonary Division, University of Florida, Gainesville, FL 32610-0486, USA. hendeles@cop.ufl.edu
Colice
Gene L
GL
Meyer
Robert J
RJ
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage; D000335:Aerosol Propellants / Q000266:history; D000420:Albuterol / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy; D001272:Atmosphere; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D017402:Chlorofluorocarbons / Q000266:history; D004867:Equipment Design; D005541:Forced Expiratory Volume / Q000187:drug effects; D033161:Government Regulation / Q000266:history; D006339:Heart Rate / Q000187:drug effects; D049672:History, 19th Century; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D006845:Hydrocarbons, Fluorinated / Q000009:adverse effects; D036501:Metered Dose Inhalers / Q000191:economics; D010126:Ozone; D014481:United States; D005466:Fluorocarbons
D000318:Adrenergic beta-Agonists; D000335:Aerosol Propellants; D000420:Albuterol; D001993:Bronchodilator Agents; D017402:Chlorofluorocarbons; D006845:Hydrocarbons, Fluorinated; D010126:Ozone; C094049:apaflurane; D005466:Fluorocarbons